<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5H4SGV3J" height="0" width="0" style="display:none;visibility:hidden">
Go Back Up
ATU (1)

Whitepaper

The 5 Silent Killers of Launch Tracking

You think your research is covered. Most launch teams do. Here’s why that’s the problem. 

Most launch teams rely on fragmented research—leaving them with data but no clear direction on what’s actually driving prescriptions. Discover the five hidden gaps slowing your launch and how to fix them before they cost you market share. 
Read the Full Whitepaper

Get the White Paper

Complete the form to get direct access to the white paper in your inbox.

One screener. All your launch answers

From Fragmented Insights to Connected Launch Intelligence

 

ATU Splash

Pharmaceutical brands invest $100M+ in launch year alone. Most run ATU, PET, PCA, and HCP-Patient dialogue research. Most believe they’re covered. The problem isn’t bad research—it’s fragmented research.

Inside this whitepaper:

  • Why do separate vendors produce data that was never designed to connect?

  • The hidden cost of recruiting the same doctors over and over.

  • How to close the velocity gap when launch dynamics shift overnight?

  • Why your awareness scores might look strong while prescriptions fall behind?

  • What integrated launch tracking actually looks like in practice?

ZoomRx Launch Excellence

ZoomRx Launch Excellence

Market Entry to Growth

 ZoomRx Launch Excellence gives biopharma brand teams an integrated framework for new therapy commercialization, connecting pre-launch assessment, message testing, competitive intelligence, promotional tracking, and patient journey analytics through a single expert team. 

SCHEDULE LAUNCH EXCELLENCE STRATEGY